Skip to content

Impact of Near-Infrared Vein Mapping on Outcomes and Satisfaction After Botox/Filler Treatment

The Impact of Near-Infrared Vein Mapping on Outcomes and Satisfaction After Botox/Filler Treatment

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04240080
Enrollment
0
Registered
2020-01-27
Start date
2020-01-10
Completion date
2024-12-31
Last updated
2024-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wrinkle

Brief summary

Researchers are studying how vein mapping impacts patient outcomes and satisfaction after facial injection procedures.

Detailed description

Facial Botox/filler injections carry risk of puncturing superficial veins, leading to bruising and pain. Our study will investigate the utility of non-invasive vein imaging (specifically near-infrared light reflection) on the incidence of pain/bruising/hematoma and patient satisfaction after facial injections. The current standard of care for facial injection procedures does not involve any modality of facial venous mapping. Vein mapping is a non-invasive, simple task that takes very little time to conduct. One risk is patient time, however maximum extra time needed will be 5 minutes during the clinical visit. This potential extra time in mind, the benefits far outweigh the risks. Two cohorts of patients will be prospectively compared following randomization, those who did have pre-procedure venous mapping prior to injection versus those who did not. Data will be analyzed with regard to bruising and swelling following injection, as well as other potential complications such as hematoma or infection, along with patient satisfaction survey information.

Interventions

DEVICEAccuvein® Veinfinder

Near-infrared light reflection utilized by healthcare providers to see superficial veins under the skin.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients pursuing aesthetic/therapeutic facial injection procedures (botox/filler)

Exclusion criteria

* Patients undergoing aesthetic facial procedures not requiring needle injection

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfactionApproximately 7-10 days following the procedureMeasured using the self-reported FACE-Q satisfaction score, using a scale of 1=definitely disagree and 4=definitely agree

Secondary

MeasureTime frameDescription
Rate of Bruising/HematomaApproximately 7-10 days following the procedureNumber of subjects to experience bruising/hematoma post facial injection procedure

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026